Stay updated on Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone
Sign up to get notified when there's something new on the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page.

Latest updates to the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page
- Check3 days agoChange DetectedThe page now indicates that the ClinicalTrials.gov data ingest will be modernized in June 2025, and the status has changed from 'Recruiting' to 'Active, not recruiting'.SummaryDifference7%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the core content.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check111 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
Stay in the know with updates to Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page.